Thanksgiving shopping is set to boost retail and tech ETFs. XRT, IBUY, ONLN, IPAY, BPAY and PSCD could be the biggest winners of the holiday spending boom.

Victoria's Secret (VSCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Eight of the top fifteen Barron's Better Bets (BBB) 'Safer' dividend stocks, including Conagra, Altria, and Verizon, are currently attractively priced for income investors. Analyst forecasts project net gains of 18.44% to 29.95% for the top ten BBB Dogs by November 2026, with an average estimated gain of 22.01%. Stocks are considered 'dogs' when their reliable dividends and lower prices result in higher yields; eight of the top ten are already at ideal pricing levels.

Also, the “ultimate cult stock,” retirement-planning advice and a look at 10 index-fund strategies.

LOS ANGELES, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Perrigo Company plc (“Perrigo” or “the Company”) (NYSE: PRGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 27, 2025 and November 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 16, 2026.

NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE: ARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Brinker International, Inc. (EAT), owner of Chili's and Maggiano's, has achieved a remarkable turnaround under CEO Kevin Hochman's leadership since 2022. EAT's growth stems from operational efficiency, menu simplification, technology upgrades, and value-driven marketing, positioning Chili's as a top competitor in casual dining. Despite market concerns about slowing growth and macroeconomic headwinds, EAT's valuation remains highly attractive with a DCF-implied 66% upside.

Dutch Bros Inc. has outperformed the Consumer Discretionary sector, driven by strong KPIs and robust consumer loyalty. BROS benefits from potential coffee tariff reductions, rising loyalty memberships, and rapid store expansion, supporting revenue growth and margin improvement. A DCF model suggests double-digit upside, with a price target of $70.50 per share, supported by favorable peer comparisons and strong financial metrics.

Discover five low P/B picks like STNE that are undervalued and show solid growth potential based on value-focused filters.

The mean of analysts' price targets for Snap (SNAP) points to a 30.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 214.1% in Actuate Therapeutics, Inc. (ACTU). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 48.6% in OppFi (OPFI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 74% in Paysign (PAYS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 53.4% upside potential for Klaviyo, Inc. (KVYO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 28.5% in Rush Street Interactive (RSI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 75% upside potential for Rapport Therapeutics, Inc. (RAPP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for LifeStance Health (LFST) points to a 30.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Applied Materials (AMAT) stock could be an appealing purchase at this time. Why? Because it offers high margins – indicative of its pricing power and capacity for cash generation – at a discounted price.

On 12/1/25, ITT, Lockheed Martin, and Northrop Grumman will all trade ex-dividend for their respective upcoming dividends. ITT will pay its quarterly dividend of $0.351 on 12/31/25, Lockheed Martin will pay its quarterly dividend of $3.45 on 12/30/25, and Northrop Grumman will pay its quarterly dividend of $2.31 on 12/17/25.

The ALPS Medical Breakthroughs ETF has staged a remarkable comeback, outperforming despite a challenging macro backdrop and small-cap weakness. SBIO benefited from a rebound in FDA drug approvals, positive clinical news, and increased M&A activity as large pharma seeks pipeline replenishment. Risks remain high for SBIO, including sector volatility, unprofitability, sensitivity to interest rates, and potential regulatory or political headwinds.